These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28562086)

  • 1. Exploring the structural requirements in multiple chemical scaffolds for the selective inhibition of Plasmodium falciparum calcium-dependent protein kinase-1 (PfCDPK-1) by 3D-pharmacophore modelling, and docking studies.
    Aher RB; Roy K
    SAR QSAR Environ Res; 2017 May; 28(5):390-414. PubMed ID: 28562086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors.
    Bhattacharjee AK; Geyer JA; Woodard CL; Kathcart AK; Nichols DA; Prigge ST; Li Z; Mott BT; Waters NC
    J Med Chem; 2004 Oct; 47(22):5418-26. PubMed ID: 15481979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring structural requirements for a class of nucleoside inhibitors (PfdUTPase) as antimalarials: first report on QSAR, pharmacophore mapping and multiple docking studies.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2013 Nov; 16(9):739-57. PubMed ID: 23701009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of antimalarial transmission blocking agents: Pharmacophore mapping of ligands active against stage-V mature gametocytes of
    Aher RB; Roy K
    J Biomol Struct Dyn; 2019 Sep; 37(14):3660-3673. PubMed ID: 30238847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification SAR modeling of diverse quinolone compounds for antimalarial potency against Plasmodium falciparum.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2014; 17(5):396-406. PubMed ID: 24372050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
    Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
    J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity.
    Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S
    SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity.
    Gupta AK; Chakroborty S; Srivastava K; Puri SK; Saxena AK
    J Chem Inf Model; 2010 Aug; 50(8):1510-20. PubMed ID: 20726605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
    Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
    J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting malaria with specific CDK inhibitors.
    Geyer JA; Prigge ST; Waters NC
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):160-70. PubMed ID: 16185941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors.
    Ojha PK; Roy K
    Med Chem; 2011 May; 7(3):173-99. PubMed ID: 21486210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Thillainayagam M; Malathi K; Ramaiah S
    J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors.
    Tseng TS; Lee YC; Hsiao NW; Liu YR; Tsai KC
    Bioorg Med Chem Lett; 2016 Jan; 26(2):265-271. PubMed ID: 26707392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
    Sharma R; Patil S; Maurya P
    SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues.
    Large JM; Osborne SA; Smiljanic-Hurley E; Ansell KH; Jones HM; Taylor DL; Clough B; Green JL; Holder AA
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6019-24. PubMed ID: 24035097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR and pharmacophore modeling of natural and synthetic antimalarial prodiginines.
    Singh B; Vishwakarma RA; Bharate SB
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):350-9. PubMed ID: 24010933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.